Digital Solutions for bEtter cAre
ConditionCancer Diagnosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12+
SponsorEuropean Institute of Oncology
About this trial
The target population includes cancer patients, caregivers, family members, healthcare providers and mental health specialists, who will be the primary end-users of the Althea platform. For patients, survivors, caregivers, and family members, the sample variables include age, gender, type and stage of disease, and time since the first diagnosis. The healthcare professionals that will be involved in this study are those who attend to oncological patients, with sample variables such as age, gender, professional role, and prior experience and training in oncology or psycho-oncology.
Eligibility criteria
Qualifiers
Healthcare professionals actually working in oncology and/or psychooncology;
Teachers of paediatric cancer patients.
Patients with a current or previous cancer diagnosis
Adequate language proficiency,
Disqualifiers
Healthcare professionals with limited oncology patient contact;
Insufficient knowledge of the local language;
Severe cognitive impairment, and/or mental disorders that prohibited their participation in the study or inadequate verbal skills that may render them incapable of informed consent (as evaluated by the clinician);
Inability to understand the study materials (as evaluated by the clinician);
Trial design
Treatments tested in this trial
- Patients, survivors, caregivers, family members and healthcare professionals
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
European Institute of Oncology
Lead sponsor
European Union
Collaborator
Source ClinicalTrials.gov